S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 97.5 TWD -0.51% Market Closed
Market Cap: 11.7B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SCI Pharmtech Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Cash from Operating Activities
NT$105.5m
CAGR 3-Years
-41%
CAGR 5-Years
-30%
CAGR 10-Years
-12%
Y
YungShin Global Holding Corp
TWSE:3705
Cash from Operating Activities
NT$1.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
-1%
Formosa Laboratories Inc
TWSE:4746
Cash from Operating Activities
NT$962.6m
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
13%
ScinoPharm Taiwan Ltd
TWSE:1789
Cash from Operating Activities
NT$604.3m
CAGR 3-Years
-7%
CAGR 5-Years
-14%
CAGR 10-Years
-2%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Cash from Operating Activities
NT$4.1B
CAGR 3-Years
437%
CAGR 5-Years
43%
CAGR 10-Years
N/A
Standard Chem & Pharm Co Ltd
TWSE:1720
Cash from Operating Activities
NT$1.3B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
8%
No Stocks Found

SCI Pharmtech Inc
Glance View

Market Cap
11.7B TWD
Industry
Pharmaceuticals

SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others

Intrinsic Value
47.66 TWD
Overvaluation 51%
Intrinsic Value
Price
S

See Also

What is SCI Pharmtech Inc's Cash from Operating Activities?
Cash from Operating Activities
105.5m TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Cash from Operating Activities amounts to 105.5m TWD.

What is SCI Pharmtech Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-12%

Over the last year, the Cash from Operating Activities growth was -66%. The average annual Cash from Operating Activities growth rates for SCI Pharmtech Inc have been -41% over the past three years , -30% over the past five years , and -12% over the past ten years .

Back to Top